ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound …
Over the last 12 months, insiders at ENDRA Life Sciences Inc. have bought $0 and sold $0 worth of ENDRA Life Sciences Inc. stock.
On average, over the past 5 years, insiders at ENDRA Life Sciences Inc. have bought $58,075 and sold $173,942 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 0 shares for transaction amount of $0 was made by UBS Group AG (Market maker/broker‑dealer) on 2024‑08‑27.
2024-08-27 | Market maker/broker-dealer | 0 – | $0 | $0 | -59.54% | |||
2023-05-18 | Chief Technology Officer | 15,000 0.8073% | $1.65 | $24,750 | -21.68% | |||
2023-05-02 | director | 83,333 3.2618% | $1.20 | $100,000 | -32.94% | |||
2022-12-09 | Chief Technology Officer | 1,500 0.1664% | $3.40 | $5,100 | -56.85% | |||
2022-11-23 | director | 10,000 0.0555% | $0.17 | $1,700 | -54.13% | |||
2022-08-22 | Chief Technology Officer | 20,000 0.1761% | $0.27 | $5,400 | -32.08% | |||
2022-08-22 | 20,000 0.1696% | $0.26 | $5,200 | -32.08% | ||||
2022-05-26 | Chief Technology Officer | 25,000 0.1712% | $0.21 | $5,250 | -6.22% | |||
2022-05-18 | Chief Technology Officer | 25,000 0.1794% | $0.22 | $5,500 | -1.74% | |||
2022-05-17 | Chief Executive Officer | 5,100 0.0316% | $0.19 | $969 | +18.62% | |||
2022-05-16 | 100,000 0.6403% | $0.20 | $19,630 | +15.61% | ||||
2021-08-26 | Sale | director | 5,000 0.3017% | $1.85 | $9,250 | -78.92% | ||
2021-08-25 | Sale | director | 45,000 2.6861% | $1.83 | $82,350 | -76.76% | ||
2021-04-07 | Sale | Chief Technology Officer | 15,000 1.2379% | $2.53 | $37,950 | -35.26% | ||
2021-03-29 | Sale | Chief Technology Officer | 18,750 1.4495% | $2.37 | $44,438 | -28.33% | ||
2021-01-13 | Sale | Chief Commercial Officer | 13,696 0.4914% | $1.10 | $15,066 | +87.50% | ||
2021-01-12 | Sale | Chief Commercial Officer | 6,304 0.2159% | $1.05 | $6,619 | +85.71% | ||
2021-01-08 | Sale | director | 10,000 0.2936% | $0.90 | $9,000 | +111.96% | ||
2021-01-08 | Sale | Chief Commercial Officer | 8,731 0.2677% | $0.94 | $8,207 | +111.96% | ||
2021-01-06 | Sale | Chief Financial Officer | 34,900 1.0245% | $0.90 | $31,410 | +131.95% |